SpaceOAR Hydrogel is a polyethylene glycol (PEG) based hydrogel designed to temporarily create space between the prostate and rectum, and reduce the radiation dose delivered to the rectum during radiation therapy. It has been clinically shown to help reduce the side effects of radiation therapy on patient quality of life.
SpaceOAR Hydrogel has been shown to minimize the risk of bowel, urinary, and sexual side effects.
Why choose SpaceOAR Hydrogel?
Visibly different: SpaceOAR Hydrogel is the only FDA-cleared radiopaque PEG-based perirectal hydrogel spacer designed for CT visibility to help optimize radiotherapy treatment planning for prostate cancer.
Proven: SpaceOAR Hydrogel is referenced in ~300 publications and reported in 3 systematic reviews and meta-analysis publications, including the SpaceOAR Hydrogel U.S. Pivotal Trial, that demonstrated space creation and reduction in dose delivered to the rectum during prostate cancer radiation therapy compared to control subjects not receiving a perirectal spacer.
Trusted: To date, 280,000 patients have been treated and that number is growing with SpaceOAR Hydrogel Portfolio — and SpaceOAR products have been purchased at 10 of the top 10 cancer centers.
